Stock Analiz

Aquestive Therapeutics, Inc. (AQST) stock forecast and price target

Price $3.91 · data as of November 13, 2026

12-month price target

Average target$9.33
Upside / downside+138.7%
Analysts9
ConsensusStrong buy
Low $6.00Average $9.33High $11.00

Gold marker: average target · white marker: today’s price ($3.91)

Analyst ratings

Strong buy 2Buy 7Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.40+32.1%$50M
Next fiscal year
ends December 31, 2027
$-0.58−45.0%$70M
Next quarter
ends December 31, 2026
$-0.11+22.4%$14M
Quarter after
ends March 31, 2027
$-0.15−237.7%$11M

Consensus of the analysts covering Aquestive Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Aquestive Therapeutics stock price target?

The average 12-month target from 9 analysts is $9.33, 138.7% above the current price of $3.91 Targets range from $6.00 to $11.00.

Is Aquestive Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 7 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Aquestive Therapeutics expected to earn?

Analysts expect EPS of $-0.40 for the fiscal year ending December 31, 2026 and $-0.58 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.